中东和非洲肺癌筛查市场预测至 2030 年 – 区域分析 – 按癌症类型 [非小细胞肺癌 (NSCLC) 和小细胞肺癌]、技术 [低剂量计算机断层扫描 (LDCT)、胸部 X 光检查、液体活检等]、年龄组（50 岁及以上和 50 岁以下）和最终用户（医院、诊断中心等）
No. of Pages: 100 | Report Code: BMIRE00029063 | Category: Life Sciences
No. of Pages: 100 | Report Code: BMIRE00029063 | Category: Life Sciences
随着该地区医疗保健意识的不断增强，该地区的肺癌筛查提供商拥有充足的机会。其中包括与地区医院和诊所合作，通过这些医院和诊所可以提供方便的肺癌筛查，并利用偏远地区的远程医疗。这种方法不仅可以早期发现肺癌，还可以改善患者的治疗结果，填补该地区医疗保健的关键空白。通过满足预防性护理不断增长的需求，这些提供者可以在前景广阔的市场中站稳脚跟，最终为改善整个地区的公共卫生和福祉做出贡献。
中东和非洲非洲肺癌筛查市场已细分为阿联酋、沙特阿拉伯、南非以及中东其他地区和地区。非洲。预计沙特阿拉伯将占据最大的市场份额，并有望在中东和中东地区适度发展。非洲。推动中东和中东地区发展的因素非洲肺癌筛查市场的增长正在提高人们对筛查和肺癌筛查的认识。政府和临床与医疗部门的诊断和不断发展的举措研究机构。伊朗、伊拉克、土耳其、科威特、卡塔尔、肯尼亚和以色列是中东其他地区和地区肺癌筛查市场的主要贡献者。非洲。根据 NCBI 发表的一份报告，在卡塔尔，肺癌是一种普遍存在的健康状况，这可归因于烟草使用量的增加。卡塔尔肺癌患者的生存率低于全球平均水平。此外，远处转移、吸烟状况和治疗史等多种因素与卡塔尔的肺癌存活率相关。由于生存率较低，卡塔尔政府强烈建议进行肺癌筛查。土耳其肺癌协会成立了“烟草控制委员会”。促进整个土耳其的烟草控制，并使公众意识到肺癌以及筛查的必要性。这些因素推动了中东其他地区和地区对肺癌筛查程序的需求。非洲
中东和中东非洲肺癌筛查市场细分
中东和非洲非洲肺癌筛查市场按癌症类型、技术、年龄组、最终用户和国家/地区进行细分。
基于癌症类型、中东和地区;非洲肺癌筛查市场分为非小细胞肺癌（NSCLC）和小细胞肺癌。非小细胞肺癌 (NSCLC) 细分市场在中东和非洲地区占有较大份额。 2022年非洲肺癌筛查市场。
以技术为基础，中东和非洲肺癌筛查市场非洲肺癌筛查市场分为胸部 X 射线、低剂量计算机断层扫描 (LDCT)、液体活检等。胸部 X 光检查在中东和非洲地区占据最大份额。 2022 年非洲肺癌筛查市场。
根据年龄组，中东和非洲肺癌筛查市场非洲肺癌筛查市场分为 50 岁及以上和 50 岁以下人群。中东和非洲地区 50 岁及以上人群占据较大份额。 2022 年非洲肺癌筛查市场。
基于最终用户、中东和非洲地区非洲肺癌筛查市场分为医院、诊断中心等。医院细分市场在中东和非洲地区占据最大份额。 2022 年非洲肺癌筛查市场。
基于国家、中东和非洲地区非洲肺癌筛查市场分为南非、沙特阿拉伯、阿联酋以及中东其他地区和地区。非洲。中东其他地区和非洲主导了中东和非洲2022 年非洲肺癌筛查市场。
Siemens AG、Koninklijke Philips NV、Canon Inc、Medtronic、GE HealthCare 和 Nuance Communications Inc 等在中东和中东地区运营的领先公司非洲肺癌筛查市场。
Strategic insights for Middle East & Africa Lung Cancer Screening involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 17.52 Million |
| Market Size by 2030 | US$ 30.11 Million |
| Global CAGR (2022 - 2030) | 7.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By 癌症类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East & Africa Lung Cancer Screening refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East & Africa Lung Cancer Screening Market is valued at US$ 17.52 Million in 2022, it is projected to reach US$ 30.11 Million by 2030.
As per our report Middle East & Africa Lung Cancer Screening Market, the market size is valued at US$ 17.52 Million in 2022, projecting it to reach US$ 30.11 Million by 2030. This translates to a CAGR of approximately 7.0% during the forecast period.
The Middle East & Africa Lung Cancer Screening Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Lung Cancer Screening Market report:
The Middle East & Africa Lung Cancer Screening Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Lung Cancer Screening Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Lung Cancer Screening Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Lung Cancer Screening Market
